We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

HELD Hellenic Dynamics Plc

0.00 (0.00%)
Last Updated: 07:34:51
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hellenic Dynamics Plc LSE:HELD London Ordinary Share GB00BRXCFB77 ORD 0.1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.00% 1.55 200 07:34:51
Bid Price Offer Price High Price Low Price Open Price
1.50 1.60 1.55 1.55 1.55
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Gen Contractor-nonres Bldgs -4.86M -0.0004 -38.75 194.22M
Last Trade Time Trade Type Trade Size Trade Price Currency
08:04:05 O 100 1.60 GBX

Hellenic Dynamics (HELD) Latest News

Hellenic Dynamics (HELD) Discussions and Chat

Hellenic Dynamics Forums and Chat

Date Time Title Posts
21/5/202417:42Hellenic Dynamics2,357
09/5/202411:22Our First Harvest313
23/1/202414:33HELD - The Positive Thread187
04/10/202316:40Hellenic Dynamics - All Views Welcome203

Add a New Thread

Hellenic Dynamics (HELD) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2024-05-21 15:41:351.55800,00012,400.00O
2024-05-21 15:21:561.5850,000789.00O
2024-05-21 14:58:471.585,50086.83O

Hellenic Dynamics (HELD) Top Chat Posts

Top Posts
Posted at 22/5/2024 09:20 by Hellenic Dynamics Daily Update
Hellenic Dynamics Plc is listed in the Gen Contractor-nonres Bldgs sector of the London Stock Exchange with ticker HELD. The last closing price for Hellenic Dynamics was 1.55p.
Hellenic Dynamics currently has 12,530,000,000 shares in issue. The market capitalisation of Hellenic Dynamics is £194,215,000.
Hellenic Dynamics has a price to earnings ratio (PE ratio) of -38.75.
This morning HELD shares opened at 1.55p
Posted at 20/5/2024 18:25 by extrader
This from Halland75, trading as Investing Genius :

.."People are clearly forgetting the 1m EUR loan over 15 years at 3.5%, this is accessible in June.."


We weren't told when this loan would be available when it was first announced in April, we learned of the midJune target date only after the emergency placing a fortnight later :

.."The proceeds of the Placing will be used for general working capital purposes up until the €1 million loan facility, announced by the Company on 22 April 2024, is received by the Company, which is EXPECTED to occur during mid-June 2024."

Then last week we learned this, about the earlier Riverfort facility ($315K principal + interest still o/s) :

.." Under the terms of the [Riverfort] Facility, the Company was required to maintain sufficient headroom in its share authorities to be able to satisfy the outstanding balance of the Facility by way of the issue of new ordinary shares in the Company, if not repaid in cash."

HELD has implicitly acknowledged that the Euro 1 m loan may not arrive, or may not arrive in time, because it has agreed [= been told by Riverfort it MUST] call a meeting 'to be held no later than 9 August 2024 [ Ed.: ie 90 days grace] in order to seek to pass resolutions to grant the necessary authority free of pre-emption to enable the Company to meets its obligations, unless the Outstanding Balance has been paid in cash, pursuant to the covenants in the Facility and to provide the directors with suitable capacity to allot shares as required from time to time..."

In plain English : HELD is calling a meeting [at Riverfort's insistence, my guess] to get authority to issue more shares in case Riverfort isn't paid off by the Euro 1 million loan.

Riverfort clearly doesn't share your confidence that the new loan will come through timeously.

Now ask yourself : why would a new lender agree to disburse (unless unavoidably required to do so), when 1/3rd of its money would be going to pay off another creditor, not to be productively invested in the business ? Especially when there seems growing (geddit?) uncertainty as to what that business is.

And - given this visible, known (in the public domain) uncertainty - why would an insurance company agree to be/stay on the hook for Euro 1 million for a measly 25K insurance premium?

'Splain that to me like I'm a 7 year-old.

Posted at 17/4/2024 21:53 by masergt
Re cultivation and numbers (from across the road):


Today 16:14

Posts: 2,465

Price: 2.35

No Opinion

Trying to get a handle on the numbers HELD are targeting.

Full pelt they target 54000kg dried flowers per annum.

They have a 40,000m2 active cultivation licence, in their 195,506 square metre facility located near Thessaloniki.

Is the site with a facility set up for vertical cultivation or is it outdoor growing?

The average yield per plant is 2oz (56.7g) of bud. So the 54000kg (1,904,794ounces) per year mark looks more aspirational at this time.

They , depending on set up need 4 separate areas. Nursery stage, growing stage, flowering stage and drying area, for continual rotational cultivation. Then packing and dispatch areas on top

Ave cycle (cutting to flower) is 14 weeks. So potentially 4 crops per year. A fully grown flowering plant is easily 0.5m2 of floor space (if they’re nettles) or 1m2 if decent. Depends how crammed in they will be.

Given its medical grade there’ll be strict controls on nutrients etc.

Even if they achieve 3-4ounces per plant average under controlled growing conditions to achieve medical grade the numbers and space currently under licence are tight.

The following numbers are pretty big for the 40,000m2 licences area in my view. Unless it is set up for vertical cultivation.

80,000 plants (0.5m2) at eg. better case average of 3ounces per plant cropped and dried is 240,000ounces per crop. On a 12-14 week rotation say 4 crops per year is 960,000 ounces or 27215.5kg. So to hit their full target they need minimum 160,000 plants if they get an average of 3 ounces per plant.

More likely 1-2 ounces so more plants in my view.

The medical site (not connected to held) I have visited, used outdoor cultivation and yielded an average of 1-2 ounces of bud per plant over 16-18 week cycle. 3 crops on a 54 week cycle.

Which is why I’m asking about the numbers HELD are targeting and type of facility they have ?
Posted at 03/4/2024 16:28 by extrader
This from investing Genius (sic) :

If - per 4 - the bank (still Piraeus?) is a big supporter (a) why is there no update re status of the loan application and (b) why is there talk of alternative funding?

If - per 5 - HELD only took GBP 350 K (we were told $450K, never mind) and has been repaying 'since October' why only announce a mix of P + I (no breakdown) PARTIAL repayment, 5 months later ?

PS as I showed in an earlier post, it's arithmetically impossible for HELD to have been repaying instalments in full since October and still only have paid off principal (AND interest) of GBP 90K...which suggests that they're in some kind of 'soft default' / forbearance, surely?

This from a man who acknowledges (point 13) that 'PR and comms haven't been good' .......and assures us that he's going to do better.
That 'New year's resolution' hasn't worn well !

Point 6 acknowledges that HELD is indeed 'running on fumes'. If RGO is liquidating its portfolio as quickly as it can (per Halland75/Investing Genius), they're hardly likely to disincentivize early payment by imposing a penalty fee, are they? What's the betting HELD will nevertheless use that as a reason for drawing out repayments ?

'There are more questions than answers...and the more we find out, the less we know', it would seem.

Same old, same old...AFAICS
Posted at 25/3/2024 08:58 by oakridge
Good morning folks.

I've received a couple of messages from other HELD investors asking if I'm still interested in this company, so may as well answer on here.

Yes, I remain fully invested and haven't sold any shares at all. I posted back in January in response to the last RNS and tend now only to post when there is something tangible to respond to. Since then I've actually doubled my holding and vastly improved my average, so I remain more than committed even if I accept the hitting of certain key operational targets has taken longer than I had anticipated.

There remains a decent level of interest in the company within the investment community, however much of this enthusiasm appears to have shifted away from ADVFN, for now at least. There are of course uncertainties and HELD remains a speculative proposition, but there are some key aspects about HELD (all of which have been discussed on here before) that remain attractive and compelling for me and the outright size of the opportunity remains undiminished imo. As someone pointed out above, KNB are openly celebrating the recent regulatory developments in the German mkt. And that is just one market from many.

I believe we have a dogged CEO working hard to position the company correctly and who has already proven, through a very lengthy listing process, that he has the best intentions. The company also has some highly prominent advisors who naturally would want only to be associated with a sincere and, ultimately successful, venture.

The recent fall of the share price has, I believe, been in response to sustained selling, compounded with a gulf in news flow. However as others have pointed to, it could be that we are now approaching the thick end of the wedge and much of the waiting and suppressing activity within the market could be behind us. I hope so anyway.

AIMO only so ADYOR and NAI etc.
Posted at 22/3/2024 15:41 by comedy
1.25mill gives you 1% of co. Only reason so out of kilter due to novice seller destroying share price and no news issued that would have absorbed his selling at a higher share price
Gives buyers with some patience a chance to buy double, sell half at double price. Free holding to enjoy the cannabis sales and the macro global bandwagon of the cannabis market predicted to grow x10 over next 9 years.
Posted at 04/3/2024 15:21 by extrader
The payment in shares just made (equiv to £21,322) appears to be the 6% drawdown fee on the First Instalment of $ 450,000 advanced last October :

- $450,000/1.25 x 6% = £ 21,600

So HELD appears to have taken 4 1/2 months to settle the drawdown fee....

The share price was 7p equivalent then, so the tardiness in settlement means that HELD has had to issue over twice as many shares in lieu...

I wonder whether this is a precursor to Drawdown of the second tranche $300,000 mentioned in the October RNS?

There's a reason CLN's are also known as 'death spiral' facilities.

Posted at 28/2/2024 07:21 by halland75
A downturn in the share price must be expected when news is not forthcoming.

No news has worked for me though, as it was made possible to buy yesterday at a price starting with a 2, and this month has allowed me to get my avg down to 5p.

Remember what Davinder has said, he will not be rushing.

You will only need one piece of news i.e PB approval, to see this share price on the move.

In regards to Piraeus Bank I think that news of approval can't be far off, I feel if it were a no, we would have heard by now.

Posted at 27/1/2024 23:23 by halland75
If you are around at some point I would really like to know what you think of this, I ask you as you were the first who pieced together a possible Pfizer link with HELD.

I think it's a very realistic possibility that Pfizer could buy HELD once IP protection is secured (see the NBC piece below where it states Pfizer abandoned its cannabis-related patents).

And remember in an interview Davinder was not opposed to a buyout.

If Pfizer partnered/bought HELD out, perhaps Pfizer now feels the time is right to continue the work they had discontinued in regards to their pain treatments.
Remember that HELD can produce different strains of medicinal cannabis, and that if HELD secured that IP protection, meaning only they can be used to supply it.

Covid is over, Greek Banking crisis is over, Large Pharmaceuticals getting into the medicinal cannabis space, and that Pfizer link....

"Big Pharma Watching, Waiting and Building Cannabis Patent Portfolio".

Published on: July 10, 2019
David Hodes

"Big pharma is working on locking up cannabis patents, creating partnerships, and standing by to use its financial muscle for more ownership of the medical cannabis industry when the time is right".

This piece from NBC News Now on Sept. 26, 2019, 5:44 PM BST By Noah Smith

A Pfizer spokesperson, Sally Beatty, said the company “abandoned” its cannabis-related patents after it ended research into treating cancer and inflammatory pain.“Years ago we investigated a class of compounds for potential therapeutic value in treating cancer pain and inflammatory pain. Our work in this area was confined to the lab, never tested in patients, and eventually discontinued,”.

Is it just wishful thinking from me, or perhaps everything is aligning now?
At this IMO, right time.
Posted at 29/11/2023 18:28 by masergt
Nothing like that gozo.

#1958. Gross overstatement. I railed against the false dawns, the numerous missed final long stop dates, the misinformation and excuses given like PJ, a long experienced corporate lawyer and senior partner, failing to anticipate the need for pan EU jurisdictional approvals; like saying the prospectus had been submitted to the FCA when it hadn't; like missing all the numbers he RNS'd when acquiring HELD. I gave him credit when the RTO completed but guessed he'd be quickly selling down his c. 2.5m shares.

#1959. N.B. Not "5 or 6 years now" gozo. My interest goes back only to February 2021 when Cathal Friel invested. MOGP closed in March 2021 creating SPC. The HELD acquisition was announced in August 2021 so you're another who bends the truth to make a point.

The HELD Prospectus - when it arrived - was nothing like that promised by PJ prior to the suspension of UK SPAC plc.

"IN BRIEF: UK SPAC to acquire Hellenic Dynamics for GBP45 million.

Mon, 02nd Aug 2021 17:29 Alliance News

UK SPAC PLC - cash shell formerly known as Mountfield Group - Shares in London suspended on entry of agreement to acquire European medicinal cannabis firm Hellenic Dynamics SA for GBP45.2 million in shares.

Payment is to be satisfied by issue of up to 9.58 billion shares at a price of 0.472 pence per share at the minimum. Proposed acquisition is expected to value UK SPAC at a minimum of GBP11.8 million at the issue price.

Deal is conditional on regulatory and shareholder approval at an upcoming general meeting, and the enlarged company being restored to trading on AIM before the long stop date of October 31.

"I am delighted that the company has been able to contract to acquire this extremely exciting and impressive company which has the ambition and the potential to become one of the major growers of medicinal cannabis in Europe," says Chair Peter Jay.

Current stock price: 0.21 pence

Year-to-date change: down 60%

By Dayo Laniyan;

Copyright 2021 Alliance News Limited. All Rights Reserved.

Then eventually, 16 months later, we got:

"Alliance News 15 November, 2022 | 3:51PM

(Alliance News) - UK SPAC PLC announced on Tuesday its proposed reverse takeover of European medical cannabis cultivation company Hellenic Dynamics has been approved by the Financial Conduct Authority.

The proposed acquisition by the London-based special purpose acquisition group entails the purchase of 10.4 billion of ordinary shares at a price of 0.3 pence each.

This price was determined after it was agreed Hellenic Dynamic's market valuation had fallen to around GBP31.2 million. It was initially valued at GBP45.2 million on August 2, 2021, when the initial terms of the transaction were announced.

UK SPAC is set to change its name to Hellenic Dynamics, with executives at Hellenic set to take charge.

It has also proposed a subscription of 250 million new ordinary shares at 0.3 pence each to raise GBP750,000.

A further GBP375,000 is planned to be raised through the issue of unsecured convertible loan notes, which can be converted at a price of 0.3 pence each.

UK SPAC said it expects to raise GBP1.1 million from both the subscription and issue of loan notes, as part of its readmission to the London Stock Exchange.

"With the announcement today of the first successful UK listing of a medical cannabis grower, all our efforts have been rewarded," said Peter Jay, UK SPAC chair.

Hellenic Dynamics Chief Executive Officer Davinder Rai said he looked forward to transitioning into a public company.

Kanabo Group PLC said on Tuesday it was delighted the FCA approved UK SPAC's proposal, after acquiring an interest of GBP750,000 worth of shares in Hellenic Dynamics on May 24.

By Greg Rosenvinge;

Copyright 2022 Alliance News Limited. All Rights Reserved."

Now compare those numbers:
- Up to 9.58 billion shares @ 0.472p values SPC at minimum £11.8m, HELD @ £45.2m.

What we got was:
- 10.4b shares @ 0.30p + 250m subscription for £750,000.
- Grants of 1.172b options + 375m warrants + other stuff taking shares to 12.53b.
- 30% dilution straight away.
- The above freebies shared out between 4 directors, 4 advisors and 6 managers!
- Associated placing and CLN to raise £1.125m, share price tanked to 0.15p.
- Alleged HELD valuation at relisting of £31.2m v. £45.2m.
- Actual valuation a week or so later of c. £12m and share price of c. 0.10p.
- Pre 100:1 consolidation share price of 0.045p. Current valuation of c. £6m.
- Loss from 5th Dec '22 RNS to Dec '23, approx 84%.
- Actual achievement? No crops, no harvests, no cash, death spiral finance.
- And what's happened to Kanabo after agreeing to buy £750,000 of shares @ 0.30p?
- Lol.

Thing is gozo, those are the facts which fools try to deny and toss aside. Not my fault if they close their eyes and lose their bet, but then you can't educate pork.
Posted at 27/11/2023 21:20 by oakridge
Halland I, if not everyone (cough!), interpreted your post earlier today as pure irony, as it was obvious HELLD would see a huge 'gain' posted on advfn post consolidation. The shares were not actually tradable today. I think most would have interpreted your post in the same way.....

masergt - refusal to answer a straight question re. Rami Ajami is duly noted......nor respond to gozo providing a good example of a very similar disclaimer, when asked by you. Nor do you pick up on my guidance to p14 of the recent presentation which states the company is GMP compliant (albeit non certified) when you said they would never stand a chance of meeting those standards. There is more you care to pass on, but I'll leave it there.

Now to your breakdown of the loan situation...

I welcome your thoughts on it and your calculations are more or less correct in principal. You have (of course!) painted a worst case scenario throughout.......but to have a worst case scenario, posted by someone who dislikes company, is a useful thing. Investors should be aware of the risks and so, with sincerity, I don't dismiss your permutations out of hand.

First let's look at the issue of dilution. Your grapple on this is really with Gozo...and isn't it really one of semantics? For me personally, I never rule dilution out of the scenario with any company I'm looking at. You posted:

"As the Facility allows for the principle amounts to be repaid in cash or a mechanism for them to be repaid in shares, a condition of the Facility is that the Company must be in a position to be able to issue new shares." GOT THAT GOZO?

You do understand, I hope, that previously with the old share structure, HELD were unable to raise money by issuing shares?....the share price having fallen below the nominal value. The company has explained its reasoning for restructuring the share capital and it should be obvious that the ability to raise funds, attract investment and structure payments is central to this.

If they choose to pay down monies owing through shares, it is possible as you state that this could be done at a lower share price and thus dilutive. The other scenario, which you are unwilling to describe is that it could also happen with a stronger share price and thus mean very minimal dilution.

You also point to the £250K in sales needed in the next 120 days (or four months) for further drawdowns. We will each have our own thoughts as to if this is realistic and whether that first (pre sold) crop is successfully grown, harvested and sold. You clearly think not. You also fail to tell readers that the arrival of a further grant, within the same time period, will also count in triggering the next drawdown.

Again, we can all have our own expectations as to the likelihood of another grant win.

If it comes in its a double whammy because not only will it represent a significant cash injection in itself, it will also have very significant implications in respect of the funding instrument that has been set up. Therefore I see grant win news as a pivotal event and of course I hope it happens.

Now, of course, your worst case scenario MIGHT play out (I'm not saying with certainty it wont), OR, a much better case scenario (ie one of a rising sp, minimal dilution, some sales and / or a grant win) could arrive. Again, I am not saying with certainty that this will happen either. Alternatively it could be a mix of the two.

What is interesting however is your insistence at every step for the worst case.....and now, most recently, with the revelation that you really don't want that to happen because you are, cough, apparently a holder too :O)

Very confusing.

Presumably, if you're a shareholder, you originally saw something you liked in the company? Has that aspect completely gone or could it still come good for you (?) That's a direct question. What aspect did you buy in on?
Hellenic Dynamics share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock